Nanobiotix (NBTX) Accounts Payables: 2019-2025

  • Nanobiotix's Accounts Payables fell 36.08% to $13.2 million in Q2 2025 from the same period last year, while for Jun 2025 it was $13.2 million, marking a year-over-year decrease of 36.08%. This contributed to the annual value of $21.4 million for FY2024, which is 8.53% up from last year.
  • Nanobiotix's Accounts Payables amounted to $13.2 million in Q2 2025, which was down 38.46% from $21.4 million recorded in Q4 2024.
  • Nanobiotix's 5-year Accounts Payables high stood at $21.4 million for Q4 2024, and its period low was $7.4 million during Q4 2021.
  • For the 3-year period, Nanobiotix's Accounts Payables averaged around $18.6 million, with its median value being $19.6 million (2023).
  • Its Accounts Payables has fluctuated over the past 5 years, first skyrocketed by 84.49% in 2023, then plummeted by 36.08% in 2025.
  • Over the past 5 years, Nanobiotix's Accounts Payables (Quarterly) stood at $7.4 million in 2021, then declined by 7.06% to $9.9 million in 2022, then skyrocketed by 84.49% to $19.6 million in 2023, then climbed by 9.11% to $21.4 million in 2024, then tumbled by 36.08% to $13.2 million in 2025.
  • Its last three reported values are $13.2 million in Q2 2025, $21.4 million for Q4 2024, and $20.6 million during Q2 2024.